3 Stocks Pushing The Health Services Industry Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 15 points (-0.1%) at 14,074 as of Monday, March 4, 2013, 12:05 PM ET. The NYSE advances/declines ratio sits at 1,220 issues advancing vs. 1,591 declining with 184 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is unchanged. On the negative front, top decliners within the industry include Intuitive Surgical ( ISRG), down 3.0%, Humana ( HUM), down 1.4%, Zimmer Holdings ( ZMH), down 0.7%, Medtronic ( MDT), down 0.7% and Aetna ( AET), down 0.5%.

TheStreet Ratings group would like to highlight 3 stocks pushing the industry lower today:

3. Fresenius Medical Care Corporation ( FMS) is one of the companies pushing the Health Services industry lower today. As of noon trading, Fresenius Medical Care Corporation is down $0.38 (-1.1%) to $33.90 on light volume Thus far, 33,572 shares of Fresenius Medical Care Corporation exchanged hands as compared to its average daily volume of 276,900 shares. The stock has ranged in price between $33.82-$34.00 after having opened the day at $33.84 as compared to the previous trading day's close of $34.28.

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides products and services for the treatment of end-stage renal disease worldwide. The company owns and operates dialysis clinics that provide dialysis treatment, and related laboratory and diagnostic services. Fresenius Medical Care Corporation has a market cap of $10.4 billion and is part of the health care sector. The company has a P/E ratio of 17.7, equal to the S&P 500 P/E ratio of 17.7. Shares are down 0.2% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Fresenius Medical Care Corporation a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Fresenius Medical Care Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Fresenius Medical Care Corporation Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

2. As of noon trading, Becton Dickinson ( BDX) is down $0.97 (-1.1%) to $87.78 on average volume Thus far, 546,681 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $87.76-$88.58 after having opened the day at $88.50 as compared to the previous trading day's close of $88.75.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $17.1 billion and is part of the health care sector. The company has a P/E ratio of 16.0, below the S&P 500 P/E ratio of 17.7. Shares are up 12.6% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate Becton Dickinson a buy, 5 analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, revenue growth, notable return on equity and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Becton Dickinson Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

1. As of noon trading, St Jude Medical ( STJ) is down $0.56 (-1.4%) to $40.84 on light volume Thus far, 765,250 shares of St Jude Medical exchanged hands as compared to its average daily volume of 3.6 million shares. The stock has ranged in price between $40.68-$41.37 after having opened the day at $41.21 as compared to the previous trading day's close of $41.40.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. St Jude Medical has a market cap of $11.6 billion and is part of the health care sector. The company has a P/E ratio of 17.2, below the S&P 500 P/E ratio of 17.7. Shares are up 13.4% year to date as of the close of trading on Friday. Currently there are 12 analysts that rate St Jude Medical a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full St Jude Medical Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

GE Confirms $11.1 Billion Transportation Merger With Wabtec

GE Confirms $11.1 Billion Transportation Merger With Wabtec

China Trade Truce, General Electric and Tesla - 5 Things You Must Know

China Trade Truce, General Electric and Tesla - 5 Things You Must Know

GE Shares Gain Amid Reports of $20 Billion Wabtec Deal

GE Shares Gain Amid Reports of $20 Billion Wabtec Deal

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)